Lmr Partners LLP Eli Lilly & CO Call Options Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 07, 2024	BUY	$772.14 - $960.02 $34.7 Million - $43.2 Million	45,000 New	45,000 $39.9 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $14.8 Million - $17.5 Million	-28,200 Reduced 70.68%	11,700 $6.82 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $14 Million - $18.7 Million	39,900 New	39,900 $18.7 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.